Latest News
Featured News
Director Dealing
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
Select the category
Scancell in-licenses Vaccitech technology to advance Modi-2 towards the clinic
First patient dosed in the expansion phase of the monotherapy arms of ModiFY
Preliminary Results for the year ended 30 April 2022
Scancell signs Commercial License Agreement with Genmab
Scancell Change of Registered Office
First patient dosed in Cohort 2 of the ModiFY Phase 1 clinical trial
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.